FILE PHOTO: A person donates blood plasma, following the coronavirus disease (COVID-19) outbreak, at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
BRUSSELS (Reuters) - The European Union has made available up to 45 million euros ($53 million/£40 million) to increase the collection of plasma from COVID-19 survivors for the treatment of people who contract the disease, a spokesman told Reuters.
The move confirms the EU's growing confidence in experimental therapies based on so-called convalescent plasma, which is currently used in hospitals for direct transfusions to critically ill patients and is being tested to develop possible medicines against COVID-19.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
